Biomed Central Ltd

SHERPA: Unknown

People

  1. Budhu
    Budhu
  2. Barker
    Barker
  3. Hirschhorn Cymerman
    Hirschhorn Cymerman
  4. Liu
    Liu
  5. Gupta
    Gupta
  6. Panageas
    Panageas
  7. Holland
    Holland
  8. Schulze
    Schulze
  9. Yang
    Yang
  10. Zhong
    Zhong

Groups

  1. Department of Medicine (6)
  2. GSK Faculty (6)
  3. Melanoma and Immunotherapeutics Service (6)
  4. Sloan Kettering Institute Postdocs (6)
  5. Solid Tumor Oncology Division (6)
  6. Melanoma Disease Management Team (3)
  7. Radiation Oncology, Department of (3)
  8. Biostatistics Service (2)
  9. Dermatology Service (2)
  10. Dermatology (2)
Search Within
  1. "Olivier De Henau"
Formats
  1. Meeting Abstract (6)
Groups
  1. Department of Medicine (6)
  2. GSK Faculty (6)
  3. Melanoma and Immunotherapeutics Service (6)
  4. Sloan Kettering Institute Postdocs (6)
  5. Solid Tumor Oncology Division (6)
  6. Melanoma Disease Management Team (3)

More Groups

People
  1. Jedd Wolchok (6)
  2. Olivier De Henau (6)
  3. Sadna Budhu (6)
  4. Taha Merghoub (6)
  5. Roberta Zappasodi (5)
  6. Billel Gasmi (3)

More People

Years
  1. 2021 (1)
  2. 2018 (2)
  3. 2017 (2)
  4. 2016 (1)
Publications
  1. Journal for ImmunoTherapy of Cancer (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • T cell immunotherapies trigger neutrophil activation to eliminate tumor antigen escape variants
    Meeting Abstract

    Hirschhorn, D.; Budhu, S.; Schröder, D.; Kraehenbuehl, L.; Flammar, A. L.; Chow, A.; Schulze, I.; Schad, S.; Ricca, J.; Gasmi, B.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn-Cymerman, D.; Ricca, J.; Gasmi, B.; De Henau, O.; Mangarin, L.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Targeting phosphatidylserine enhances the anti-tumor response to radiation therapy and immune checkpoint blockade in a preclinical melanoma model
    Meeting Abstract

    Budhu, S.; Giese, R.; Gupta, A.; Schad, S.; De Henau, O.; Zappasodi, R.; Campesato, L.; Barker, C.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn, D.; Ricca, J.; Gasmi, B.; Mangarin, L. M.; De Henau, O.; Budhu, S.; Li, Y.; Cortez, C.; Xia, Y.; Zhong, H.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Phosphatidylserine targeting antibody in combination with tumor radiation and immune checkpoint blockade promotes anti-tumor activity in mouse B16 melanoma
    Meeting Abstract

    Budhu, S.; Giese, R.; De Henau, O.; Zappasodi, R.; Campesato, L. F.; Gupta, A.; Barker, C.; Freimark, B.; Wolchok, J. D.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Phosphatidylserine targeting antibody in combination with checkpoint blockade and tumor radiation therapy promotes anticancer activity in mouse melanoma
    Meeting Abstract

    Budhu, S.; De Henau, O.; Zappasodi, R.; Schlunegger, K.; Freimark, B.; Hutchins, J.; Barker, C. A.; Wolchok, J. D.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save